Trial Profile
Corifollitropin Alfa Followed by Hp-HMG Versus Recombinant FSH in Young Poor Ovarian Responders. A Multicentre Randomized Controlled Clinical Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Corifollitropin alfa (Primary) ; Ganirelix (Primary) ; Menotropin (Primary) ; Urofollitropin
- Indications Infertility
- Focus Therapeutic Use
- Acronyms COMPORT
- 21 Jun 2016 Status changed from recruiting to completed.
- 16 Jun 2016 The trial was completed in Belgium.
- 05 Aug 2015 Planned End Date changed from 1 Feb 2014 to 1 Jan 2016 as per ClinicalTrials.gov record.